Neurology
Alzheimer's & Dementia
Epilepsy
Headache & Migraine
Multiple Sclerosis
Neurology
Conferences
- FDA approves five-day dosing regimen of Eisai's Dacogen for MDS
- FDA refuses to file NDA for Adventrx's investigational NSCLC treatment
- FDA grants ImmunoGen's investigational skin cancer compound orphan drug status
- FDA grants permission to Synta to resume testing of elesclomol in cancer
- Boxed warning added to Plavix label regarding possible reduced efficacy in certain patients
- Private FFS MA plans may be linked with higher costs for beneficiaries, GAO report shows
- Pediatric subspecialty telephone consultations may be cost-saving for Medicaid, research reveals
- Use of mental health services greater in health plans with parity in cost sharing, data find
- Public opinions appear split on health care affordability, satisfaction, survey finds
- In Brief: California Supreme Court
AAN 2007 Annual Meeting
April 28 - May 5, 2007 Boston, MA- Neurologic implications in sleep abnormalities
- Patients with EDS deficient in prostaglandin D synthase
- Eszopiclone appears to improve sleep in people with primary insomnia without next-day impairments in cognitive, psychomotor performance, driving abilities
- Undiagnosed sleep disorders appear common in patients with MS, fatigue, analysis reveals
- Adding eszopiclone to escitalopram improves insomnia symptoms in individuals with insomnia, GAD, study shows
- Metabolic syndrome associated with increased risk of developing cognitive impairment, results indicate
- New research in RLS, sleep apnea
- SleepMed Insomnia Index may help characterize insomnia symptoms in patients with RLS; scores correlate with RLS severity
- Among pregnant women, those with migraine have increased risk of vascular events, findings show
- Undiagnosed sleep disorders appear common in patients with MS, fatigue, analysis reveals
- Preeclampsia associated with epilepsy in offspring, data show
- Undiagnosed sleep disorders appear common in patients with MS, fatigue, analysis reveals
- Stimulants reduce later risk for developing substance use disorders, smoking in girls with ADHD
- Prenatal exposure to sodium valproate linked to greater autism spectrum disorder risk, according to early results
- FDA panel clears fampridine-SR
